Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Urban Health
Published in: Journal of Urban Health 6/2020

01-12-2020 | Opioids

Geospatial Variations and Neighborhood Deprivation in Drug-Related Admissions and Overdoses

Authors: Julien Cobert, Paul M. Lantos, Mark M. Janko, David G. A. Williams, Karthik Raghunathan, Vijay Krishnamoorthy, Eric A. JohnBull, Atilio Barbeito, Padma Gulur

Published in: Journal of Urban Health | Issue 6/2020

Login to get access

Abstract

Drug overdoses are a national and global epidemic. However, while overdoses are inextricably linked to social, demographic, and geographical determinants, geospatial patterns of drug-related admissions and overdoses at the neighborhood level remain poorly studied. The objective of this paper is to investigate spatial distributions of patients admitted for drug-related admissions and overdoses from a large, urban, tertiary care center using electronic health record data. Additionally, these spatial distributions were adjusted for a validated socioeconomic index called the Area Deprivation Index (ADI). We showed spatial heterogeneity in patients admitted for opioid, amphetamine, and psychostimulant-related diagnoses and overdoses. While ADI was associated with drug-related admissions, it did not correct for spatial variations and could not account alone for this spatial heterogeneity.
Appendix
Available only for authorised users
Literature
1.
Visconti AJ, Santos GM, Lemos NP, Burke C, Coffin PO. Opioid overdose deaths in the city and county of San Francisco: prevalence, distribution, and disparities. J Urban Health. 2015;92(4):758–72.CrossRef
2.
Garfield J. E D: fatal overdose trends in major us cities: 1990–1997. Addiction Research & Thery. 2001;9(5):425–36.CrossRef
3.
Brownstein JS, Green TC, Cassidy TA, Butler SF. Geographic information systems and pharmacoepidemiology: using spatial cluster detection to monitor local patterns of prescription opioid abuse. Pharmacoepidemiol Drug Saf. 2010;19(6):627–37.CrossRef
4.
Havens JR, Talbert JC, Walker R, Leedham C, Leukefeld CG. Trends in controlled-release oxycodone (OxyContin) prescribing among Medicaid recipients in Kentucky, 1998-2002. J Rural Health. 2006;22(3):276–8.CrossRef
5.
Dasgupta N, Jonsson Funk M, Brownstein J. Comparing unintentional opioid poisoning mortality in metropolitan and non-metropolitan counties, United States, 1999–2003. In: Thomas Y, Richardson D, Cheung I, editors. Geography and drug addiction. New York: Springer; 2008.
6.
McLafferty S. Placing substance abuse. In: Thomas Y, Richardson D, Cheung I, editors. Geography and drug addiction. New York: Springer; 2008.
7.
Paulozzi LJ, Ryan GW. Opioid analgesics and rates of fatal drug poisoning in the United States. Am J Prev Med. 2006;31(6):506–11.CrossRef
8.
Paulozzi LJ, Xi Y. Recent changes in drug poisoning mortality in the United States by urban-rural status and by drug type. Pharmacoepidemiol Drug Saf. 2008;17(10):997–1005.CrossRef
9.
Rigg KK, Monnat SM, Chavez MN. Opioid-related mortality in rural America: geographic heterogeneity and intervention strategies. Int J Drug Policy. 2018;57:119–29.CrossRef
10.
Zerzan JT, Morden NE, Soumerai S, Ross-Degnan D, Roughead E, Zhang F, et al. Trends and geographic variation of opiate medication use in state Medicaid fee-for-service programs, 1996 to 2002. Med Care. 2006;44(11):1005–10.CrossRef
11.
Health UoWSoMaP: Area Deprivation Index. v2.0 edn. Madison, WI; 2015.
12.
Kind AJ, Jencks S, Brock J, Yu M, Bartels C, Ehlenbach W, et al. Neighborhood socioeconomic disadvantage and 30-day rehospitalization: a retrospective cohort study. Ann Intern Med. 2014;161(11):765–74.CrossRef
13.
Lantos PM, Hoffman K, Permar SR, Jackson P, Hughes BL, Kind A, et al. Neighborhood disadvantage is associated with high cytomegalovirus seroprevalence in pregnancy. J Racial Ethn Health Disparities. 2018;5(4):782–6.CrossRef
14.
Sheets L, Petroski GF, Jaddoo J, Barnett Y, Barnett C, Kelley LEH, et al. The effect of neighborhood disadvantage on diabetes prevalence. AMIA Annu Symp Proc. 2017;2017:1547–53.PubMed
15.
Singh GK. Area deprivation and widening inequalities in US mortality, 1969-1998. Am J Public Health. 2003;93(7):1137–43.CrossRef
16.
Besag J, York J, Mollie A. Bayesian image restoration, with two applications in spatial statistics. Ann Inst Stat Math. 1991;43(1):1–49.CrossRef
17.
Cerda M, Ransome Y, Keyes KM, Koenen KC, Tardiff K, Vlahov D, et al. Revisiting the role of the urban environment in substance use: the case of analgesic overdose fatalities. Am J Public Health. 2013;103(12):2252–60.CrossRef
18.
Cerda M, Ransome Y, Keyes KM, Koenen KC, Tracy M, Tardiff KJ, et al. Prescription opioid mortality trends in New York City, 1990-2006: examining the emergence of an epidemic. Drug Alcohol Depend. 2013;132(1–2):53–62.CrossRef
19.
Green CR, Ndao-Brumblay SK, West B, Washington T. Differences in prescription opioid analgesic availability: comparing minority and white pharmacies across Michigan. J Pain. 2005;6(10):689–99.CrossRef
20.
Burgess DJ, Phelan S, Workman M, Hagel E, Nelson DB, Fu SS, et al. The effect of cognitive load and patient race on physicians’ decisions to prescribe opioids for chronic low back pain: a randomized trial. Pain Med. 2014;15(6):965–74.CrossRef
21.
Piercefield E, Archer P, Kemp P, Mallonee S. Increase in unintentional medication overdose deaths: Oklahoma, 1994-2006. Am J Prev Med. 2010;39(4):357–63.CrossRef
22.
Hall AJ, Logan JE, Toblin RL, Kaplan JA, Kraner JC, Bixler D, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA. 2008;300(22):2613–20.CrossRef
23.
Joynt M, Train MK, Robbins BW, Halterman JS, Caiola E, Fortuna RJ. The impact of neighborhood socioeconomic status and race on the prescribing of opioids in emergency departments throughout the United States. J Gen Intern Med. 2013;28(12):1604–10.CrossRef
24.
Ndlovu M, Bedson J, Jones PW, Jordan KP. Pain medication management of musculoskeletal conditions at first presentation in primary care: analysis of routinely collected medical record data. BMC Musculoskelet Disord. 2014;15:418.CrossRef
25.
Gebauer S, Salas J, Scherrer JF. Neighborhood socioeconomic status and receipt of opioid medication for new back pain diagnosis. J Am Board Fam Med. 2017;30(6):775–83.CrossRef
26.
Durfey SNM, Kind AJH, Buckingham WR, DuGoff EH, Trivedi AN. Neighborhood disadvantage and chronic disease management. Health Serv Res. 2019;54(Suppl 1):206–16.CrossRef
27.
Ho JY. The contribution of drug overdose to educational gradients in life expectancy in the United States, 1992-2011. Demography. 2017;54(3):1175–202.CrossRef
28.
Pouget ER, Fong C, Rosenblum A. Racial/ethnic differences in prevalence trends for heroin use and non-medical use of prescription opioids among entrants to opioid treatment programs, 2005-2016. Subst Use Misuse. 2018;53(2):290–300.CrossRef
29.
McClellan CB. Disparities in opioid related mortality between United States counties from 2000 to 2014. Drug Alcohol Depend. 2019;199:151–8.CrossRef
30.
Mosher H, Zhou Y, Thurman AL, Sarrazin MV, Ohl ME. Trends in hospitalization for opioid overdose among rural compared to urban residents of the United States, 2007-2014. J Hosp Med. 2017;12(11):925–9.CrossRef
31.
Wagner J, Neitzke-Spruill L, O’Connell D, Highberger J, Martin SS, Walker R, et al. Understanding geographic and neighborhood variations in overdose death rates. J Community Health. 2019;44(2):272–83.CrossRef
32.
Strom BL. Data validity issues in using claims data. Pharmacoepidemiol Drug Saf. 2001;10(5):389–92.CrossRef
33.
Seth P, Scholl L, Rudd RA, Bacon S. Overdose deaths involving opioids, cocaine, and psychostimulants - United States, 2015-2016. MMWR Morb Mortal Wkly Rep. 2018;67(12):349–58.CrossRef
34.
Presription Drug Overdose Data & Statistics - Guide to ICD-9-CM and ICD-10 Codes Related to Poisoning and Pain. In: Prevention DoUI, Version 1.3 editor. Atlanta, GA: National Center for Injury Prevention and Control - Centers for Disease Control and Prevention; 2013.
Metadata
Title
Geospatial Variations and Neighborhood Deprivation in Drug-Related Admissions and Overdoses
Authors
Julien Cobert
Paul M. Lantos
Mark M. Janko
David G. A. Williams
Karthik Raghunathan
Vijay Krishnamoorthy
Eric A. JohnBull
Atilio Barbeito
Padma Gulur
Publication date
01-12-2020
Publisher
Springer US
Keywords
Opioids
Opioids
Published in
Journal of Urban Health / Issue 6/2020
Print ISSN: 1099-3460
Electronic ISSN: 1468-2869
DOI
https://doi.org/10.1007/s11524-020-00436-8

Other articles of this Issue 6/2020

Journal of Urban Health 6/2020 Go to the issue

OriginalPaper

Impact of COVID-19 Pandemic on Drug Overdoses in Indianapolis

EditorialNotes

COVID-19 Containment in Asia’s Largest Urban Slum Dharavi-Mumbai, India: Lessons for Policymakers Globally

ReviewPaper

Impacts of Gentrification on Health in the US: a Systematic Review of the Literature

Brief Report

Opioid Overdose–Related Emergency Department Visits and Accidental Deaths during the COVID-19 Pandemic

OriginalPaper

Assessing Urban Health Inequities through a Multidimensional and Participatory Framework: Evidence from the EURO-HEALTHY Project

OriginalPaper

Housing Stability and Hepatitis C Infection for Young Adults Who Inject Drugs: Examining the Relationship of Consistent and Intermittent Housing Status on HCV Infection Risk